مرور Volume 7, Issue 1 بر اساس موضوع "Iran."
در حال نمایش موارد 1 - 3 از 3
-
Comparison of the Quality of Life among Patients with Idiopathic Thrombocytopenic Purpura and Healthy People in Isfahan, Iran
(Tehran, Iranian Blood and Cancer Society, 2014-11-01)Background: Quality of life has been used as an important tool to understand illnesses impact in recent decades. Idiopathic thrombocytopenic purpura is a chronic disease which affects the individuals’ quality of life. The ...
-
The Frequency of Genotype D of Hepatitis B Virus in Isfahan, Iran
(Tehran, Iranian Blood and Cancer Society, 2014-11-01)Background: Approximately 600,000 deaths occur every year as a result of the acute and chronic consequences of hepatitis B virus infection. Ten different hepatitis B virus genotypes have been identified with distinct ...
-
Prevention from Doxorubicin Cardiotoxicity by Available Protective Agents in Iran
(Tehran, Iranian Blood and Cancer Society, 2014-11-01)Doxorubicin, used in pediatric chemotherapy regimens, has cardiotoxic effects. Dexrazoxane is co-administrated with doxorubicin to prevent its cardiotoxicity. Here we have explored some alternative food or drugs to be ...



